Effect of subtype and psychiatric comorbidities on methylphenidate treatment in adults with attention-deficit hyperactivity disorder;Methylphenidatbehandlung bei erwachsenen mit aufmerksamkeitsdefizit-/ hyperaktivitätsstörung: Bedeutung von störungssubtyp und aktueller psychiatrischer komorbidität

Nervenarzt

Volumn 78, Issue 3, 2007, Pages 328-337

  Sobanski, E ^a   Alm, B ^a   Krumm, B ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Adult attention deficit hyperactivity disorder; Comorbidity; Depression; Immediate release methylphenidate; Psychopharmacotherapy

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COGNITION; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG EFFICACY; HUMAN; INFORMATION PROCESSING; OUTCOME ASSESSMENT; PSYCHIATRY; TREATMENT OUTCOME; ADOLESCENT; CLASSIFICATION; FEMALE; HOSPITALIZATION; MALE; MENTAL DISEASE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; METHYLPHENIDATE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33847717926     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2068-0     Document Type: Article

References (26)

1. Kessler RC, Berglund P, Chiu WT et al. (2004) The US National comorbidity survey replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 13:69-92
2. Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsenus mit Unterstützung der DGPPN. Nervenarzt 74:939-946
3. Kooij JJS, Burger H, Boonstra M et al. (2004) Efficacy and safety of methylphenidate in 45 adults with attention deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 34:973-982
4. Spencer T, Wilens T, Biederman J et al. (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 56:434-443
5. Dorrego MF, Carnavaro L, Kuzis G et al. (2002) A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 14:289-295
6. Mattes JA, Roswell L, Oliver H (1984) Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41:1059-1063
7. Faraone SV, Spencer T, Aleardi M et al. (2004) Meta-analysis of the efficacy of methylphenidate for treating adults with attention-deficit/ hyperactivity. J Clin Psychopharmacol 24:24-29
8. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. (DSM-IV). American Psychiatric Association, Washington DC
9. Hautzinger M, Bailer M, Worall H et al. (1995) Beck Depressions Inventar (BDI), 2. überarbeitete Aufl. Hogrefe, Göttingen
10. Franke GH (2002) SCL-90-R. Symptomcheckeliste von L.R. Derogatis - Deutsche Version, 2. vollständig überarbeitete und neu normierte Aufl. Beltz, Göttingen
11. Brown TE (1996) Brown attention-deficit disorder scales manual. The Psychological Corporation, San Antonia
12. Retz-Junginger P, Retz W, Blocher D et al. (2003) Reliabilität und Validität der Wender-Utah-Rating-Scale Kurzform. Nervenarzt 74:987-993
13. Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes klinisches Interview für DSM-IV, Achse I und II. Hogrefe, Göttingen
14. Horn W (1983) Leistungsprüfsystem, 2. Erweiterte Aufl. Hogrefe, Göttingen
15. Horn W (2004) Prüfsystem für Schul- und Bildungsberatung für 6. bis 13. Klassen-revidierte Fassung (PSB-R 6-13). Neubearbeitung von Lukesch H, Mayrhofer S. Hogrefe, Göttingen
16. Reitan RM (1979) Trail Making Test (TMT). Hogrefe, Göttingen
17. Millstein RB, Wilens TE, Biederman J et al. (1997) Presenting ADHD symptoms in subtypes in clinically referred adults with ADHD. J Atten Disord 2:159-166
18. Murphy KR, Barkley RA, Bush T (2002) Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational and clinical history. J Nerv Ment Dis 190:147-157
19. Manuzza S, Kleien RG, Bessler A et al. (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank and psychiatric status. Arch Gen Psychiatry 50:565-567
20. Wender PH, Reimherr FW, Wood D et al. (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547-552
21. Swanson JH, Kraemer HC, Hinshaw SR et al. (2001) Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168-179
22. Gillberg C, Gillberg IC, Rasmussen P et al. (2004) Co-existing disorders in ADHD-implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13:80-92
23. Schulte-Markwort M, Warnke A (Hrsg) (2004) Methylphenidat. Thieme, Stuttgart
24. Findling RL (1996) Open-label treatment of comorbid depression and attentional disorders with a co-administration of serotonin reuptake inhibitors and psychostimulants in children, dolescents and adults: a case series. J Child Adolesc Psychopharmacol 6:165-175
25. Hornig-Rohan M, Amsterdam JD (2002) Venalfaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog Neuropsychopharmacol Biol Psychiatry 26:585-589
26. Brown TE (ed) (2000) Attention-deficit disorders and comorbidities in children, adolescents and adults. American Psychiatric Press, Washington DC